切换至 "中华医学电子期刊资源库"

中华乳腺病杂志(电子版) ›› 2025, Vol. 19 ›› Issue (01) : 54 -57. doi: 10.3877/cma.j.issn.1674-0807.2025.01.010

综述

乳腺腺样囊性癌的研究进展
黄小辉1,2, 王紫娟2, 周围2, 郭琼2, 廖妮2, 谭米多2,()   
  1. 1.412000 株洲,吉首大学株洲临床学院
    2.412000 株洲,中南大学湘雅医学院附属株洲医院乳腺外科
  • 收稿日期:2024-09-02 出版日期:2025-02-01
  • 通信作者: 谭米多
  • 基金资助:
    湖南省自然科学基金资助项目(2024JJ7654)

Research progress of adenoid cystic carcinoma of the breast

Xiaohui Huang, Zijuan Wang, Wei Zhou, Qiong Guo, Ni Liao, Niduo Tan()   

  • Received:2024-09-02 Published:2025-02-01
  • Corresponding author: Niduo Tan
引用本文:

黄小辉, 王紫娟, 周围, 郭琼, 廖妮, 谭米多. 乳腺腺样囊性癌的研究进展[J/OL]. 中华乳腺病杂志(电子版), 2025, 19(01): 54-57.

Xiaohui Huang, Zijuan Wang, Wei Zhou, Qiong Guo, Ni Liao, Niduo Tan. Research progress of adenoid cystic carcinoma of the breast[J/OL]. Chinese Journal of Breast Disease(Electronic Edition), 2025, 19(01): 54-57.

乳腺腺样囊性癌是一种罕见的特殊类型三阴性乳腺癌,其病理特征和生物学行为与其他三阴性乳腺癌差异较大。 乳腺腺样囊性癌主要由腺上皮、肌上皮和基底样细胞构成,癌细胞常表现为CD117 阳性和原癌基因MYB 阳性。 乳腺腺样囊性癌预后较好,手术是主要的治疗手段,其次是辅助放射治疗,是否需要辅助化疗尚无一致的标准。 目前尚缺乏针对乳腺腺样囊性癌治疗的指南或共识,因此临床医师需要了解该病的临床特点,避免过度治疗。 本文对乳腺腺样囊性癌的临床特征、病理组织学特点、生物学行为、诊断和治疗等方面的研究进展进行综述,旨在为深入了解乳腺腺样囊性癌并为临床诊疗提供依据。

[1]
Zhang W, Fang Y, Zhang Z, et al. Management of adenoid cystic carcinoma of the breast: a single-institution study[J]. Front Oncol,2021,11:621012.
[2]
Liao HY, Zhang WW, Sun JY, et al. The clinicopathological features and survival outcomes of different histological subtypes in triple-negative breast cancer[J]. J Cancer, 2018,9(2):296-303.
[3]
Meng M, Xie LJ, Qiu X. A case of adenoid cystic carcinoma of the breast[J]. Asian J Surg, 2024,47(5):2415-2416.
[4]
Li JX, Zhang XM, Xiao YX, et al. Male adenoid cystic carcinoma of the breast[J]. J Med Cases, 2021,12(12):503-510.
[5]
Wan D, Zhou H, Zhang Y. Adenoid cystic carcinoma of the breast in a male patient: a case report and literature review[J]. Front Oncol,2022,12:905997.
[6]
Gillie B, Kmeid M, Asarian A, et al. Adenoid cystic carcinoma of the breast with distant metastasis to the liver and spleen: a case report[J].J Surg Case Rep, 2020,2020(11):rjaa483.
[7]
Zhang D, Li L, Ma F. Prognosis stratification and postoperative radiation therapy utilization in adenoid cystic carcinoma of the breast[J]. Breast, 2022,66:40-48.
[8]
Liu Z, Wang M, Wang Y,et al. Diagnosis of adenoid cystic carcinoma in the breast: a case report and literature review[J]. Arch Med Sci,2022,18(1):279-283.
[9]
Boujelbene N, Khabir A, Boujelbene N, et al. Clinical review--breast adenoid cystic carcinoma[J]. Breast, 2012,21(2):124-127.
[10]
Gordillo C, Chukus A. Adenoid cystic carcinoma: a case of rare breast cancer[J]. Radiol Case Rep, 2021,17(3):690-692.
[11]
Liu Y, Zhu L, Guo L, et al. Tremendous and infrequently adenoid cystic carcinoma of the breast without any metastasis for more than 20 years: a case report[J]. Medicine (Baltimore), 2024,103(34):e39461.
[12]
Guldogan N, Esen G, Kayadibi Y, et al. Adenoid cystic carcinoma of the breast: multimodality imaging findings and review of the literature[J]. Acad Radiol, 2023,30(6):1107-1117.
[13]
Kashiwagi S, Asano Y, Ishihara S, et al. Adenoid cystic carcinoma of the breast: a case report[J]. Case Rep Oncol, 2019,12(3):698-703.
[14]
Agafonoff S, Sobolewski A,Braverman TS. Adenoid cystic carcinoma of the breast - discordant size on imaging and pathology: a case report and review of literature[J]. Ann Med Surg (Lond), 2019,43:1-4.
[15]
Glazebrook KN, Reynolds C, Smith RL, et al. Adenoid cystic carcinoma of the breast[J]. AJR Am J Roentgenol, 2010,194(5):1391-1396.
[16]
Kasagawa T, Suzuki M, Doki T, et al. Two cases of adenoid cystic carcinoma: preoperative cytological findings were useful in determining treatment strategy[J]. Breast Cancer, 2006,13(1):112-116.
[17]
Tang W, Peng WJ, Gu YJ, et al. Imaging manifestation of adenoid cystic carcinoma of the breast[J]. J Comput Assist Tomogr, 2015,39(4):523-530.
[18]
Hogan KO, Fan F. Diagnosis of metastatic adenoid cystic carcinoma of the breast on pleural fluid cytology in a 60-year-old male [J]. Diagn Cytopathol, 2021,49(4):E172-E174.
[19]
Little AJ, Seline AE, Swick BL, et al. Cutaneous metastasis of breast adenoid cystic carcinoma to the scalp[J]. J Cutan Pathol, 2016,43(8):684-687.
[20]
Yang P, Yang S, Zhong X, et al. Breast adenoid cystic carcinoma in a 19-year-old man: a case report and review of the literature[J]. World J Surg Oncol, 2015,13:19.
[21]
Burusapat C, Buarabporn N, Wongchansom K, et al. Mammary adenoid cystic carcinoma presenting with ductal carcinoma in situ and axillary lymph node metastasis[J]. J Surg Case Rep, 2020,2020(2):rjz362.
[22]
Miyai K, Schwartz MR, Divatia MK, et al. Adenoid cystic carcinoma of breast:recent advances[J]. World J Clin Cases,2014,2(12):732-741.
[23]
刘卓, 胡小木,包芸,等.不典型乳腺腺样囊性癌1 例[J].临床与实验病理学杂志,2024,40(3):331-332.
[24]
Sołek JM, Braun M, Kalwas M, et al. Adenoid cystic carcinoma of the breast -an uncommon malignancy with unpredictable clinical behaviour.A case series of three patients[J]. Contemp Oncol (Pozn), 2020,24(4):263-265.
[25]
Hara Y, Yamaguchi R, Yano H, et al. Adenoid cystic carcinoma,solid-basaloid subtype of the breast: a case report[J]. Int J Surg Pathol, 2023,31(4):460-463.
[26]
Zhang M, Liu Y, Yang H, et al. Breast adenoid cystic carcinoma: a report of seven cases and literature review[J]. BMC Surg, 2022,22(1):113.
[27]
Bhutani N, Kajal P, Singla S. Adenoid cystic carcinoma of the breast:experience at a tertiary care centre of northern india[J]. Int J Surg Case Rep, 2018,51:204-209.
[28]
de Gregorio A, Friedl TWP, Hering E, et al. Ki67 as proliferative marker in patients with early breast cancer and its association with clinicopathological factors[J]. Oncology, 2021,99(12):780-789.
[29]
Mastropasqua MG, Maiorano E, Pruneri G, et al. Immunoreactivity for c-kit and p63 as an adjunct in the diagnosis of adenoid cystic carcinoma of the breast[J]. Mod Pathol, 2005,18(10):1277-1282.
[30]
Welsh JL, Keeney MG, Hoskin TL, et al. Is axillary surgery beneficial for patients with adenoid cystic carcinoma of the breast? [J]. J Surg Oncol, 2017,116(6):690-695.
[31]
West RB, Kong C, Clarke N, et al. MYB expression and translocation in adenoid cystic carcinomas and other salivary gland tumors with clinicopathologic correlation[J]. Am J Surg Pathol,2011,35(1):92-99.
[32]
Ji J, Zhang F, Duan F, et al. Distinct clinicopathological and genomic features in solid and basaloid adenoid cystic carcinoma of the breast[J].Sci Rep, 2022,12(1):8504.
[33]
Olszewska M, Głuszek S. Adenoid cystic carcinoma of the breast[J].Med Stud, 2017,33(4): 304-307.
[34]
Kiss O,To··kés AM, Spisak S, et al. MicroRNA-profiling in breast-and salivary gland-derived adenoid cystic carcinomas[J]. Orvosi Hetilap,2013,154(25):963-968.
[35]
Sumpio BE, Jennings TA, Merino MJ, et al. Adenoid cystic carcinoma of the breast. Data from the connecticut tumor registry and a review of the literature[J]. Ann Surg, 1987,205(3):295-301.
[36]
Rabban JT, Swain RS, Zaloudek CJ, et al. Immunophenotypic overlap between adenoid cystic carcinoma and collagenous spherulosis of the breast: potential diagnostic pitfalls using myoepithelial markers[J].Mod Pathol, 2006,19(10):1351-1357.
[37]
Panwar H, Ingle P, Santosh T, et al. FNAC of breast lesions with special reference to iac standardized reporting and comparative study of cytohistological grading of breast carcinoma[J]. J Cytol, 2020,37(1):34-39.
[38]
Marinho ML, Tafuri A, da Silva Ramos CA, et al. Adenoid cystic carcinoma of the breast: case report[J]. Mastology, 2021,31: 1-5.
[39]
Hara Y, Yamaguchi R, Yano H, et al. Adenoid cystic carcinoma,solid-basaloid subtype of the breast: a case report[J]. Int J Surg Pathol, 2023, 31(4): 460-463.
[40]
许华, 李胜水,邢辉,等.乳腺实性型腺样囊性癌并淋巴结转移1 例[J].诊断病理学杂志,2023,30(6):607-608.
[41]
Butcher MR, White MJ, Rooper LM, et al. MYB RNA in situ hybridization is a useful diagnostic tool to distinguish breast adenoid cystic carcinoma from other triple-negative breast carcinomas[J]. Am J Surg Pathol, 2022, 46(7): 878-888.
[42]
Rakha EA, Coimbra NDM,Hodi Z,et al. Immunoprofile of metaplastic carcinomas of the breast[J]. Histopathology, 2017, 70(6): 975-985.
[43]
Treitl D, Radkani P, Rizer M, et al. Adenoid cystic carcinoma of the breast,20 years of experience in a single center with review of literature[J]. Breast Cancer, 2018,25(1):28-33.
[44]
Sun JY, Wu SG, Chen SY, et al. Adjuvant radiation therapy and survival for adenoid cystic carcinoma of the breast[J]. Breast, 2017,31:214-218.
[45]
Khanfir K, Kallel A, Villette S, et al. Management of adenoid cystic carcinoma of the breast: a rare cancer network study[J]. Int J Radiat Oncol Biol Phys, 2012,82(5):2118-2124.
[46]
Huang T, Fang Q,Niu L,et al. Optimal surgical procedure for treating early-stage adenoid cystic carcinoma of the breast[J]. Sci Rep, 2023,13(1):10222.
[47]
Gomez-Seoane A, Davis A, Oyasiji T. Treatment of adenoid cystic carcinoma of the breast:is postoperative radiation getting its due credit?[J]. Breast, 2021,59:358-366.
[48]
Li L, Zhang D, Ma F. Adenoid cystic carcinoma of the breast may be exempt from adjuvant chemotherapy[J]. J Clin Med, 2022,11(15):4477.
[49]
National Comprehensive Cancer Network. Clinical practice guidelines in oncology: breast cancer (version 4, 2022)[EB/OL].[2024-11-23].https:/ /www.nccn.org/guidelines/guidelines-detail? category=1&id=1419.
[50]
Yang L, Wang C, Liu M, et al. Evaluation of adjuvant treatments for adenoid cystic carcinoma of the breast: a population-based, propensity score matched cohort study from the seer database[J]. Diagnostics(Basel), 2022,12(7):1760.
[51]
Wenig E, Birhiray RE. Novel treatment options in advanced adenoid cystic carcinoma of the breast[J]. J Clin Oncol, 2021, 39 (15):13071-13071.
[52]
Zhang H, Zhang N, Moran MS, et al. Special subtypes with favorable prognosis in breast cancer: a registry-based cohort study and network meta-analysis[J]. Cancer Treat Rev, 2020,91:102108.
[1] 张忠涛, 高加勒, 姚宏伟. 新辅助放化疗联合免疫治疗局部进展期直肠癌的现状与前景[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(02): 119-122.
[2] 姚宏伟, 孙丽婷, 吴偲, 舒文龙, 高加勒, 杨正阳, 吴国聪, 张忠涛. 新辅助放化疗联合免疫治疗局部进展期直肠癌的探索与实践[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(02): 123-127.
[3] 王乾宇, 杜峻峰, 李世拥. 新辅助放化疗联合免疫治疗局部进展期直肠癌的突破与挑战[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(02): 128-131.
[4] 吴楚营, 叶凯. 不同部位胃肠道间质瘤的腹腔镜手术策略[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(02): 224-227.
[5] 杨培容, 潘刚, 周春霞. 胰腺癌术后胰瘘的危险因素及治疗进展[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(02): 228-230.
[6] 苏明, 唐丹萍, 王萍, 何谦. 乳腺癌改良根治术后即刻乳房重建的方法选择研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(02): 231-234.
[7] 李华志, 曹广, 刘殿刚, 张雅静. 不同入路下行肝切除术治疗原发性肝细胞癌的临床对比[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 52-55.
[8] 高杰红, 黎平平, 齐婧, 代引海. ETFA和CD34在乳腺癌中的表达及与临床病理参数和预后的关系研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 64-67.
[9] 陈浩, 王萌. 胃印戒细胞癌的临床病理特征及治疗选择的研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 108-111.
[10] 韩萌萌, 冯雪园, 马宁. 乳腺癌改良根治术后桡神经损伤1例[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 117-118.
[11] 苏浩, 曹明誉, 郭一苇, 刘小彭. 前列腺增生术后压力性尿失禁相关研究进展[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(01): 103-110.
[12] 朱洪浩, 范新祥. 广东省医学会泌尿外科疑难病例多学科会诊(第18期)——女性尿道癌[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(01): 120-124.
[13] 中华医学会外科学分会疝与腹壁外科学组, 中国医师协会外科医师分会疝和腹壁外科专家工作组. 腹股沟疝诊疗指南(2024 版)[J/OL]. 中华疝和腹壁外科杂志(电子版), 2025, 19(01): 1-8.
[14] 中华医学会器官移植学分会, 中国医师协会器官移植医师分会. 肝移植术后急性移植物抗宿主病诊疗中国专家共识(2024 版)[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(01): 1-12.
[15] 王闪闪, 赵海涛. 胆道癌转化手术策略[J/OL]. 中华消化病与影像杂志(电子版), 2025, 15(01): 1-5.
阅读次数
全文


摘要